The company’s partnership with the largest human genome sequencing project in the world will increase scientists’ understanding of genetic diseases and help create new interventions. Here, a look at the breakthroughs that have guided the understanding of the power of DNA.

More than 37.5 million people worldwide are affected by this common type of heart arrhythmia—and by 2025, the number of cases will increase by 60%. Learn the facts behind this heart condition, plus one patient’s diagnosis story.

With a unique disposable camera the size of a pinkie finger, Eric Buehlmann and his team pioneered a better—and easier—way for doctors to perform back procedures.

The goal of precision medicine is to develop individualized treatments based on a patient’s genetic profile. Here’s how Johnson & Johnson is harnessing this cutting-edge field of tailor-made medicine.

Johnson & Johnson has been dedicated to developing innovative treatments for blood cancers for nearly 20 years. Scientist Kodandaram “Ram” Pillarisetti is at the forefront of the company’s commitment to working toward its goal of one day eliminating the disease.

Every year, roughly 80,000 Americans receive a bladder cancer diagnosis. Many endure difficult and burdensome treatments in an attempt to fight the disease. But new innovations just might change that.